Caspi, Oren

Modelling the long QT syndrome with induced pluripotent stem cells

Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature

Cardiac electrophysiology and arrhythmiasPluripotent Stem Cells Research

Cited by 1,049

Tissue engineering of vascularized cardiac muscle from human embryonic stem cells

Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I. H. M., Gepstein, L., & Levenberg, S. (2007) · Circulation Research

Tissue Engineering and Regenerative MedicinePluripotent Stem Cells Research

Cited by 558

A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring

Alpert, A., Pickman, Y., Leipold, M., Rosenberg-Hasson, Y., Ji, X., Gaujoux, R., Rabani, H., Starosvetsky, E., Kveler, K., Schaffert, S., et al. (2019) · Nature Medicine

Single-cell and spatial transcriptomicsGenetics, Aging, and Longevity in Model Organisms

Cited by 513

Transplantation of a Tissue-Engineered Human Vascularized Cardiac Muscle

Lesman, A., Habib, M., Caspi, O., Gepstein, A., Arbel, G., Levenberg, S., & Gepstein, L. (2010) · Tissue Engineering Part A

Tissue Engineering and Regenerative MedicineCongenital heart defects research

Cited by 241

Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells

Caspi, O., Huber, I., Gepstein, A., Arbel, G., Maizels, L., Boulos, M., & Gepstein, L. (2013) · Circulation Cardiovascular Genetics

Cardiovascular Effects of ExercisePluripotent Stem Cells Research

Cited by 186

Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies

Catapano, A. L., Mikhailova, E., Navar, A. M., Banka, P., Corral, P., Saxena, M., Steg, P. G., Verma, S., Kordahi, A. Y., Mendizabal, G., et al. (2026) · JACC

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 19